VU-0155069 is a potent and selective phospholipase D1 (PLD1) inhibitor.

KY-226 is a novel, selective, orally bioactive and allosteric inhibitor of protein tyrosine phosphatase 1B (PTP1B) with an IC50 of 0.25 μM, and without PPARγ agonist activity.

ACA [also known as N-(p-amylcinnamoyl) Anthranilic Acid] is a broad-spectrum inhibitor of phospholipase A2 (PLA2) and a TRP channel blocker.

BAPTA, an intercellular and selective fluorescent Ca2+ chelator, is a novel and potent neuroprotective agent usef for cerebral ischemia.

BAPTA, an intercellular Ca2+ chelator, is a novel and potent neuroprotective agent usef for cerebral ischemia.

LCL521 is a novel and potent acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the lysosomal acid sphingomyelinase (ASMase).

CAY10650 (CAY-10650) is a novel and highly potent inhibitor of cytosolic phospholipase A2α (cPLA2α) (IC50 = 12 nM) with anti-inflammatory activity.

GW4869 HCl (GW-4869; GW-69A; GW-554869A), the dihydrochloride salt of GW4869, is a neutral, cell permeable and noncompetitive inhibitor of sphingomyelinase (SMase) (IC50 = 1 μM) and is most widely used pharmacological agent for blocking exosome generation.

CAY10594 is a novel potent phospholipase D2 inhibitor able to ameliorate acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.

EA4, a quinone derivative, is a novel and potent a rPLA2 inhibitor that inhibits rPLA2 with a Ki of 130 µM.